RGCC North America

RGCC North America RGCC was launched in 2004 by genetics pioneer Dr. Ioannis Papasotiriou with a view to developing personalized treatment options to treat cancer effectively.

RGCC North America provides individualized cellular and molecular laboratory analyses for licensed healthcare practitioners, offering observations under defined analytical conditions. Today, RGCC is a global organization, working in collaboration with branch offices and distributors to provide services worldwide. Our North America team is driven by a profound commitment to advancing the field of personalized cancer care. Our goal is simple yet powerful: to empower people facing cancer with tailored insights that can change the course of their journey. The team has extensive expertise in developing and providing personalized cancer genetics tests for doctors and patients that include testing cancer cells for sensitivity and resistance to chemotherapy treatment and a large range of natural substances. In addition to personalized cancer testing, our team is actively involved in pharmaceutical research, identifying novel targets for new drug development. Contact us today to know how we can help you in your cancer journey. https://myrgcc.com/contact-us/

09/17/2026

Not All Circulating Tumor Cells Appear Alone

This segment explores the concept of cellular clustering and examines how different cell populations may exhibit distinct biological characteristics and behaviors.

Want to continue the discussion? Dr. Ghen’s next lecture on the subject is coming up soon! DM us for details.

Primary Topics:
Cellular clusters
Cellular heterogeneity
Circulating tumor cells
Population characteristics

Join us for two days on chronic inflammatory illness in November 🌴🌴  RGCC is sponsoring the LymeBytes® SymposiumNovember...
09/15/2026

Join us for two days on chronic inflammatory illness in November 🌴🌴

RGCC is sponsoring the LymeBytes® Symposium
November 13th -14th in Pompano Beach, FL

This Symposium is the premier functional medicine conference on complex, chronic infection-driven illnesses and the gateway to education, research, and community discourse for practitioners and scientists. Sessions cover Lyme, co-infections, environmental illness, immune dysfunction, and chronic inflammation. Friday evening: beach dinner.

Register: https://shop.lymebytes.com/?tid=8ELgVVVF9n

🌿 We're pleased to announce that RGCC will be attending the 2026 National Nutrition Standard Symposium: The Modern Woman...
09/14/2026

🌿 We're pleased to announce that RGCC will be attending the 2026 National Nutrition Standard Symposium: The Modern Woman's Health Through All Life's Stages.

Join us in Fort Lauderdale for four days of expert-led sessions on topics including adrenal health, peri-/pre-/post-menopause, nutrition in puberty, stress and mental health, female athletes, bone density, HRT, and more. We look forward to joining the national conversation on women’s health and connecting with practitioners and experts in this space.

📅 September 24th–27th, 2026
📍Fort Lauderdale, FL
🔗https://www.nationalnutritionstandard.org/annual-symposium/info

Learn more about how practitioners can utilize our laboratory tests and preparations, and practitioner resources. https://myrgcc.com.

Not intended as medical advice. For informational purposes only.

09/11/2026

What Is EMT?

An overview of epithelial-mesenchymal transition (EMT), including changes in cellular properties and a discussion of EpCAM-positive and EpCAM-negative cell populations.

Want to continue the discussion? Dr. Ghen’s next lecture on the subject is coming up soon! DM us for details.

Primary Topics:
EMT
Epithelial-mesenchymal transition
Cell population characteristics
EpCAM biology
Analytical approaches

09/04/2026

How Do Tumor Cells Enter the Bloodstream?

This educational segment explores several biological concepts associated with cellular movement, including local invasion, basement membrane interactions, proteases, and cellular survival mechanisms.

Want to continue the discussion? Dr. Ghen’s next lecture on the subject is coming up soon! DM us for details.

Primary Topics:
Cellular movement
Local invasion
Proteases
Basement membrane interactions
Cellular survival concepts

📄 Peer-reviewed publication 📄 An open-access study appears in microPublication Biology (Caltech Library): "Long-term cul...
08/28/2026

📄 Peer-reviewed publication 📄

An open-access study appears in microPublication Biology (Caltech Library): "Long-term cultivation shifts transcriptomic profile of HCT-116 cells." The research was carried out by scientists at RGCC Central Europe.

The question behind it: how long can a widely used cancer cell line stay genetically stable in culture before its gene expression begins to drift?

Using HCT-116 — a colon carcinoma line used in labs worldwide — the researchers tracked transcriptome-wide gene expression across 25 passages (roughly 16 weeks of continuous culture).

What they observed:

🔬 Gene expression stayed largely stable up to around passage 20, with only minimal differential expression.
🔬 Beyond that point, genes involved in cell proliferation and cell death began to shift — observations consistent with gradual cellular drift.

Based on the study findings, transcriptomic profiles remained largely stable through earlier passages, while additional changes were observed following extended cultivation.

📖 Read the open-access paper: https://www.micropublication.org/journals/biology/micropub-biology-002074

For educational purposes only. Not medical advice.

08/24/2026

What Are Circulating Tumor Cells (CTCs)?

What are circulating tumor cells, and why are they studied in cancer research? In this clip, Dr. Ghen provides an overview of CTCs and discusses how cells from a primary tumor may enter the bloodstream.

Want to continue the discussion? Dr. Ghen’s next lecture on the subject is coming up soon! DM us for details.

Primary Topics:
Circulating tumor cells (CTCs)
Cancer biology
Cellular circulation
Educational overview

🧬 What Is Next-Generation Sequencing? Next-Generation Sequencing (NGS) is a laboratory technology used to read genetic m...
08/20/2026

🧬 What Is Next-Generation Sequencing?

Next-Generation Sequencing (NGS) is a laboratory technology used to read genetic material - determining the precise order of the building blocks that make up DNA and RNA. 🔬

DNA is written in an alphabet of just four bases - A, T, G, and C - arranged in sequences that carry biological information. "Sequencing" simply means reading that order, one base at a time. RNA is read in much the same way. By working out these sequences, scientists can study the genetic and molecular information held within a sample.

A defining feature of NGS is that it can read large numbers of DNA or RNA fragments at the same time, producing a high volume of genetic data from a single run. 📊

At a high level, the process moves through a few stages:

🧪 Sample & library preparation — genetic material is isolated and made ready for sequencing
🔍 Sequencing — the instrument reads the order of bases across many fragments in parallel
💻 Data analysis — specialized bioinformatics tools process, organize, and analyze the resulting data

Because it generates so much data, NGS pairs hands-on laboratory work with computational analysis. It remains one of the core technologies for studying genetic and molecular information today.

For educational purposes only. Not medical advice.

RGCC is sponsoring LymeBytes® 🌴🌴  Spend two days in South Florida with the clinicians, researchers, and practitioners wo...
08/13/2026

RGCC is sponsoring LymeBytes® 🌴🌴
Spend two days in South Florida with the clinicians, researchers, and practitioners working to increase understanding of Lyme, co-infections, mold illness, and chronic inflammatory conditions. Expect emerging research and real conversations - plus a Friday beach dinner. CMEs available for in-person attendees.

Register: https://shop.lymebytes.com/?tid=8ELgVVVF9n

🧪 Peer-reviewed publication A study carried out by RGCC scientists has been published in RSC Advances, published by the ...
08/11/2026

🧪 Peer-reviewed publication

A study carried out by RGCC scientists has been published in RSC Advances, published by the Royal Society of Chemistry.

Title: "Comparative binding and activity analysis of known serine hydroxymethyltransferase (SHMT) inhibitors in biochemical assays."

The study focused on an enzyme called serine hydroxymethyltransferase, which plays a role in cellular metabolism. A handful of small molecules are known to inhibit this enzyme — but detailed biochemical data on exactly how they bind and how strongly they act has been missing from the scientific literature.

To help close that gap, the team:

🔬 Adapted an existing laboratory assay and applied it to measure the activity of SHMT inhibitors.
🔬 Ran a side-by-side comparison of nine known inhibitors, producing new binding and activity data.

The result is a reproducible laboratory method that can be used to study these enzymes. This practical contribution is grounded in a commitment to rigorous, methods-focused laboratory science.

📖 Read the open-access paper: https://pubs.rsc.org/ra/article/doi/10.1039/d5ra08513f/1272344/Comparative-binding-and-activity-analysis-of-known

Learn more about our science and laboratory methods at https://myrgcc.com

Address

8354 Northfield Boulevard Building G, Suite 3700
Denver, CO
80238

Alerts

Be the first to know and let us send you an email when RGCC North America posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to RGCC North America:

Share